Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neuroprotective agents target molecular mechanisms of disease in ALS.

Neuroprotective agents target molecular mechanisms of disease in ALS. Drug Discov Today. 2015 Jan; 20(1):65-75.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.